WO2000076966A3 - Derives d'indolinylamide - Google Patents
Derives d'indolinylamide Download PDFInfo
- Publication number
- WO2000076966A3 WO2000076966A3 PCT/EP2000/005114 EP0005114W WO0076966A3 WO 2000076966 A3 WO2000076966 A3 WO 2000076966A3 EP 0005114 W EP0005114 W EP 0005114W WO 0076966 A3 WO0076966 A3 WO 0076966A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- indolinylamide
- derivatives
- antiviral drugs
- compounds
- antiviral
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU62623/00A AU6262300A (en) | 1999-06-16 | 2000-06-05 | Indolinylamide derivatives |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19927415A DE19927415A1 (de) | 1999-06-16 | 1999-06-16 | Indolinylharnstoffderivate |
DE19927415.0 | 1999-06-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000076966A2 WO2000076966A2 (fr) | 2000-12-21 |
WO2000076966A3 true WO2000076966A3 (fr) | 2001-07-19 |
Family
ID=7911403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/005114 WO2000076966A2 (fr) | 1999-06-16 | 2000-06-05 | Derives d'indolinylamide |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU6262300A (fr) |
DE (1) | DE19927415A1 (fr) |
WO (1) | WO2000076966A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001256733A1 (en) * | 2000-05-16 | 2001-11-26 | Takeda Chemical Industries Ltd. | Melanin-concentrating hormone antagonist |
MA41140A (fr) | 2014-12-12 | 2017-10-17 | Cancer Research Tech Ltd | Dérivés de 2,4-dioxo-quinazoline-6-sulfonamide en tant qu'inhibiteurs de la parg |
MA41179A (fr) | 2014-12-19 | 2017-10-24 | Cancer Research Tech Ltd | Composés inhibiteurs de parg |
CA3018026A1 (fr) | 2016-04-06 | 2017-10-12 | Innovative Molecules Gmbh | Derives d'aminothiazole utiles en tant qu'agents antiviraux |
MA50609B1 (fr) | 2017-10-05 | 2023-03-31 | Innovative Molecules Gmbh | Énantiomères de thiazoles substitués utilisés comme composés antiviraux |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997024343A1 (fr) * | 1995-12-29 | 1997-07-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | Derives de phenylthiazole dotes de proprietes anti virus de l'herpes |
-
1999
- 1999-06-16 DE DE19927415A patent/DE19927415A1/de not_active Withdrawn
-
2000
- 2000-06-05 WO PCT/EP2000/005114 patent/WO2000076966A2/fr active Application Filing
- 2000-06-05 AU AU62623/00A patent/AU6262300A/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997024343A1 (fr) * | 1995-12-29 | 1997-07-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | Derives de phenylthiazole dotes de proprietes anti virus de l'herpes |
Also Published As
Publication number | Publication date |
---|---|
DE19927415A1 (de) | 2000-12-21 |
AU6262300A (en) | 2001-01-02 |
WO2000076966A2 (fr) | 2000-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY134892A (en) | Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use | |
MXPA03010201A (es) | Derivados de 2-piridin-ciclohexan-1,4-diamina sustituidos. | |
AU2003282094A1 (en) | Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments | |
HK1065027A1 (en) | Carboxamide-substituted phenylurea derivatives andmethod for production thereof as medicaments | |
WO2001010816A3 (fr) | Derives de 2-dialkylaminoalkylbiphenyle | |
MY134880A (en) | Thiazolyl amide derivatives | |
WO2003014079A8 (fr) | Polymorphe stable de flibanserine, procede de preparation associe et utilisation dudit polymorphe dans la preparation de medicaments | |
AU3364101A (en) | Substituted piperazine derivatives, production thereof and use thereof as medicaments | |
WO2001047928A3 (fr) | Nouveaux imidazo[1,3,5]triazinones et leur utilisation | |
AU2002238855A1 (en) | N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same | |
WO2001027110A3 (fr) | Derives d'imidazo-3-yl-amine bicycliques substitues sur le sixieme chainon | |
WO2002030870A3 (fr) | Derives de c-cyclohexylmethylamine substitues | |
WO2002010152A3 (fr) | Nouveaux derives d'indol et leur utilisation comme medicaments | |
HUP0204360A3 (en) | Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament and medicaments containing said compounds | |
WO2001002350A3 (fr) | Nouveaux aminosulfonamides et amidosulfonamides utilises en tant qu'agents antiviraux | |
WO2004106307A3 (fr) | Nouveaux derives d’imidazoles, leur preparation et leur utilisation en tant que medicament | |
EP1076057A4 (fr) | Febrifugine et isofebrifugine, et leurs procedes de preparation | |
WO2001049654A3 (fr) | Derives d'aminomethyle-phenyle-cyclohexane substitues | |
HUP0600084A2 (en) | Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient | |
WO2003089449A3 (fr) | Composes aminoalkylsteroles avec activite anti-tumeur et neuroprotective | |
AU7904600A (en) | Substituted piperazine derivatives, the production and use thereof as medicaments | |
WO2000076966A3 (fr) | Derives d'indolinylamide | |
WO2001049651A3 (fr) | Derives d'aminomethyle-phenyle-cyclohexane | |
WO2004043900A3 (fr) | Derives de 4-alkyl-/4-alcenyl-/4-alcynylmethyl-/1-aryl-cyclohexylamine | |
AU2003252467A1 (en) | Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |